Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | SCN4A | P35499 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22570767 | 1.00 | SLC2A1 (0.50) | SLC2A1POLBSCN4AKDM4EALDH1A1 | |
| SCHEMBL4851319 | 1.00 | SLC2A1 (0.50) | SLC2A1POLBSCN4AKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL2913067 | 0.98 | SLC2A1 (0.53) | SLC2A1POLBSCN4AKDM4EALDH1A1 | |
| Iodide SCHEMBL4740378 | 0.98 | SLC2A1 (0.49) | SLC2A1POLBSCN4AKDM4EALDH1A1 | |
| SCHEMBL869237 | 0.94 | SLC2A1 (0.57) | SLC2A1SCN4ACA2HTR2AHRH1 | |
| SCHEMBL13132265 | 0.94 | SLC2A1 (0.57) | SLC2A1SCN4ACA2HTR2AHRH1 | |
| SCHEMBL4080852 | 0.92 | SLC2A1 (0.60) | SLC2A1CA2HTR2A | |
| SCHEMBL4990564 | 0.92 | SLC2A1 (0.60) | SLC2A1CA2HTR2A | |
| SCHEMBL10589876 | 0.92 | SLC2A1 (0.60) | SLC2A1CA2HTR2A | |
| SCHEMBL4071245 | 0.92 | SLC2A1 (0.60) | SLC2A1CA2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | claimed |
| CN-119798092-A | Imine intermediate of indenofloxacin, cis-indene intermediate and preparation method thereof | 宁夏格瑞精细化工有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-4472995-A2 | CONJUGATED HEPCIDIN MIMETICS | Protagonist Therapeutics, Inc. (US) | 2024-12-11 | — | — | EP | claimed |
| WO-2023150618-A2 | CONJUGATED HEPCIDIN MIMETICS | PROTAGONIST THERAPEUTICS, INC. (US) | 2023-08-10 | — | — | WO | claimed |
| CN-113620906-B | Method for preparing ethylenediamine and ethanolamine derivatives by photocatalytic biomass polyalcohol | 中国科学院大连化学物理研究所 | 2023-05-19 | — | — | CN | claimed |
| CN-114975803-A | Quantum dot light-emitting device, display panel, display device and manufacturing method | 京东方科技集团股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2022-06-23 | — | — | US | claimed |
| CN-113620906-A | Method for preparing ethylenediamine and ethanolamine derivatives by photocatalysis of biomass polyols | 中国科学院大连化学物理研究所 | 2021-11-09 | — | — | CN | claimed |
| WO-2020130592-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | 서울대학교산학협력단 | 2020-06-25 | — | — | WO | claimed |
| CN-105085733-B | A kind of catalyst component for olefin polymerization preparation method and corresponding catalyst | 中国石油化工股份有限公司 | 2017-10-03 | — | — | CN | claimed |
| US-20090076292-A1 | Rosuvastatin intermediates and process for the preparation of rosuvastatin | TEVA PHARMACEUTICAL INDUSTRIES LTD. | 2009-03-19 | — | — | US | claimed |
| EP-2032587-A2 | ROSUVASTATIN INTERMEDIATES AND PROCESS FOR THE PREPARATION OF ROSUVASTATIN | Teva Pharmaceutical Industries Ltd. (IL) | 2009-03-11 | — | — | EP | claimed |
| WO-2008130678-A2 | ROSUVASTATIN INTERMEDIATES AND PROCESS FOR THE PREPARATION OF ROSUVASTATIN | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-10-30 | — | — | WO | claimed |
| CN-1951974-A | Metal-free 1k-polyurethane system | DEGUSSA (DE) | 2007-04-25 | — | — | CN | claimed |
| EP-1375549-B1 | Self crosslinkable polyurethane-polyurea dispersions | BAYER MATERIALSCIENCE AG (DE) | 2006-11-29 | — | — | EP | claimed |
| CN-1703199-A | Aggregate with enhanced deformability comprising at least three amphiphiles for improved transport through a semi-permeable barrier and use of non-invasive drugs in vivo, in particular through the skin | IDEA AG (DE) | 2005-11-30 | — | — | CN | claimed |
| US-5208357-A | CHIRAL METALLOCENE COMPOUNDS AND PREPARATION THEREOF BY ATTACHMENT OF CHIRAL CENTER | EXXON CHEMICAL PATENTS, INC. (US) | 1993-05-04 | — | — | US | claimed |
| WO-1992012117-A1 | CHIRAL METALLOCENE COMPOUNDS AND PREPARATION THEREOF BY ATTACHMENT OF A CHIRAL CENTER | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-23 | — | — | WO | claimed |
| US-4637885-A | LUBE OIL, AMINE OR QUATERNARY AMMONIUM SALT OF PHOSPHORIC ACID | KAO CORPORATION (JP) | 1987-01-20 | — | — | US | claimed |
| US-4143092-A | POLYURETHANE-DERIVED PLASTICIZER FOR POLYACRYLONITRILE PRINTING ROLLS | SAMUEL BINGHAM COMPANY (US) | 1979-03-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220194969-A1 | METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME | HCN4, SLC46A1, FES | SLC2A1 335/4885POLB 2638/4885SCN4A 381/4885 |
| US-20250361280-A1 | CONJUGATED HEPCIDIN MIMETICS | HAMP, VIP, HDGF | SLC2A1 1615/4885POLB 4599/4885SCN4A 4246/4885 |
| US-20090076292-A1 | Rosuvastatin intermediates and process for the preparation of rosuvastatin | HMGCR, PCSK9, CYP4A11 | SLC2A1 1108/4885POLB 2224/4885SCN4A 2156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.